Oxidized LDL ELISA

$594.00
Catalog
30-7810

The Oxidized Low-Density Lipoprotein (ox-LDL) ELISA kit is intended for the quantitative determination of ox-LDL in Human EDTA plasma and serum. The kit recognizes MDA-modified Apo lipoprotein B 100 containing less than 60 MDA units/molecule.

  • Controls and standards
  • Wide detection range of 9-250 ng/mL
  • Small sample volumes at 10 µL
  • Colorimetric detection
Research Use Only. Not for Use in Diagnostic Procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
9-250 ng/mL
Sensitivity
9 ng/mL
Sizes
96 Wells
Sample Types
EDTA Plasma, Plasma, Serum
Inc Time Hour
2
Inc Time Minute
20
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
10
Detection
Colorimetric
Low - density lipoproteins (LDL) are cholesterol-rich lipoproteins whose main task is to transport cholesterol from the liver to extrahepatic tissue. LDL consists of an apolipoprotein B100 (Apo B100), cholesterol esters, free cholesterol and phospholipids. Elevated LDL cholesterol is a risk factor for arteriosclerosis and thus coronary heart disease. However, its oxidized forms, such as e.g. B. MDA-LDL (malondialdehyde modified low density lipoprotein). Lipid peroxidation is a natural process and only when lipid peroxidation exceeds the antioxidant cell protection is the balance disturbed and cell damage occurs. In oxidative metabolic situations, the oxidation of polyunsaturated fatty acids produces, among other things , MDA , which is a reactive dialdehyde. Attack of LDL produces MDA-modified LDL (MDA-LDL). Native LDL is taken up by macrophages via specific LDL receptors, which are expressed to a reduced extent when they are saturated with LDL (feedback). LDL modified by oxidation is no longer recognized as native and is therefore not taken up via regulated and specific receptors. Instead, there is unchecked absorption via non-specific receptors, such as e.g. B. so-called scavenger receptors. The rapid uptake of the oxidized LDLs into the macrophages leads to the conversion of these into cholesterol-rich foam cells. The increased occurrence of foam cells is considered one of the first signs of the formation of atherosclerotic plaques.

Oxidized LDL ELISA

30-7810

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

Targeted Solutions for Gastroenterology
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
View Now
 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
View Now
GLP-1 Amide Elisa
Product Data: Active GLP-1 (7-36) amide Chemiluminescence ELISA
ALPCO’s Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.